[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@SiemprePulpo Avatar @SiemprePulpo The Octopus Investing

The Octopus Investing posts on X about $dnpwa, $nvo, $jmt, $lonn the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence finance XXX% stocks XXXX% countries XXXX% cryptocurrencies XXXX%

Social topic influence $dnpwa #6, $nvo 1.03%, $jmt 1.03%, $lonn 0.51%, $zab 0.51%, $340m 0.51%, $21b 0.51%, nvo 0.51%, poland 0.51%, $eurwa XXXX%

Top accounts mentioned or mentioned by @drcm4t @joinyellowbrick @paulcerro @mdbbolsa @investseekers @zissoucapital @stonkmetal @investordotdev @invesquotes @valueinves12771 @kuxing86 @mikelgoiko68816 @researchitgg @labinversion @agnombela @vanguardeconomy @logos88 @evfcfaddict @benzg24 @inversorgrunion

Top assets mentioned Novo-Nordisk (NVO) Lossless (LSS) Danaher Corporation (DHR) Hims & Hers Health, Inc. (HIMS)

Top Social Posts #

Top posts by engagements in the last XX hours

"Lonza Group AG $LONN is up +6.5% this morning on its H1 2025 results: 🔹Revenue: +19.0% at CER 🔹CDMO revenue: +23.1% at CER 🔹 Utilization improvement despite weaker CGT & microbial demand 🔹New facilities ramp-up within schedule 🔹Guidance raised: +1% both in sales & EBITDA Looking at positive results in pharma glass packaging manufacturers CROs & CDMOs results biotech demand looks to be finally back 😎"
X Link @SiemprePulpo 2025-07-23T08:27Z 1996 followers, 3564 engagements

"$DNP.WA 🦖 sells convenience in the Polish rural areas. Meanwhile $ZAB 🐸 is the convenience store reigning in the cities (I was shocked this year when I visited Gdansk to see one every XXX meters). Great read to understand their business model 👇"
X Link @SiemprePulpo 2025-08-31T07:33Z 1996 followers, 1278 engagements

"🚨 BREAKING $NVO expands it's rare diseases portfolio by acquiring Omeros' Ziltenibart (OMS906) asset a selective MASP-3 inhibitor for PNH and kidney diseases. Price: $340M + milestones up to $2.1B + royalties. I thought the plan was to focus in diabetes & obesity 🤔"
X Link @SiemprePulpo 2025-10-15T13:06Z 1996 followers, 1152 engagements

"Market consolidation is happening in Poland. That would eventually lead to only the best players prevailing and the returns increasing due to less aggressive competition. Good for $DNP.WA"
X Link @SiemprePulpo 2025-09-18T10:16Z 1996 followers, XXX engagements

"Anyone has a long/short investment thesis on Lectra $LSS"
X Link @SiemprePulpo 2025-09-16T15:51Z 1996 followers, XXX engagements

"We just hit XXX subs on my 🐝hiiv 📬letter Some of the content you can find there covers the following companies: 🔸Jernimo Martins $JMT 🔸Pandora $PNDORA 🔸Novo Nordisk $NVO 🔸Lonza $LONN.SW 🔸Hims&Hers $HIMS 🔸Danaher $DHR 🔸Theon International $THEON Big props to all of you for the supportlets keep this growth rolling 😎"
X Link @SiemprePulpo 2025-03-31T08:36Z 1996 followers, 4790 engagements

"Any phase III candidate has the same prospects of becoming best in class blockbuster. They have cleaned the phase III R&D pipeline too. Maybe I am too old fashioned but I expect a CEO especially a new one to do what he said the company was going to do. This acquisition is not the case"
X Link @SiemprePulpo 2025-10-16T05:04Z 1996 followers, XX engagements

"Full $PNDORA.CO earnings review published today. After last friday's -XX% stock price drop today I am sharing with you: 🔸Financial statements review 🔸Main KPIs discussion 🔸Highlights from management call 🔸Risks revision Check my profile for more👤"
X Link @SiemprePulpo 2025-08-18T18:04Z 1996 followers, 1796 engagements